MX2017006275A - Inhibidor de cinasa aurora a. - Google Patents

Inhibidor de cinasa aurora a.

Info

Publication number
MX2017006275A
MX2017006275A MX2017006275A MX2017006275A MX2017006275A MX 2017006275 A MX2017006275 A MX 2017006275A MX 2017006275 A MX2017006275 A MX 2017006275A MX 2017006275 A MX2017006275 A MX 2017006275A MX 2017006275 A MX2017006275 A MX 2017006275A
Authority
MX
Mexico
Prior art keywords
methyl
fluoro
aurora
kinase inhibitor
pyrazol
Prior art date
Application number
MX2017006275A
Other languages
English (en)
Spanish (es)
Inventor
Robert Henry James
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2017006275A publication Critical patent/MX2017006275A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
MX2017006275A 2014-11-14 2015-11-06 Inhibidor de cinasa aurora a. MX2017006275A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462079742P 2014-11-14 2014-11-14
PCT/US2015/059390 WO2016077161A1 (en) 2014-11-14 2015-11-06 Aurora a kinase inhibitor

Publications (1)

Publication Number Publication Date
MX2017006275A true MX2017006275A (es) 2017-08-14

Family

ID=54697647

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006275A MX2017006275A (es) 2014-11-14 2015-11-06 Inhibidor de cinasa aurora a.

Country Status (41)

Country Link
US (2) US9637474B2 (tr)
EP (2) EP3473619B8 (tr)
JP (1) JP6159029B2 (tr)
KR (1) KR101930182B1 (tr)
CN (1) CN107108567B (tr)
AR (1) AR102463A1 (tr)
AU (1) AU2015347043B2 (tr)
BR (1) BR112017007239B1 (tr)
CA (1) CA2963473C (tr)
CL (1) CL2017001209A1 (tr)
CO (1) CO2017004784A2 (tr)
CR (1) CR20170158A (tr)
CY (2) CY1121334T1 (tr)
DK (2) DK3218366T3 (tr)
DO (1) DOP2017000111A (tr)
EA (1) EA032102B1 (tr)
EC (1) ECSP17029203A (tr)
ES (2) ES2716732T3 (tr)
HR (2) HRP20190324T1 (tr)
HU (2) HUE051530T2 (tr)
IL (1) IL251406B (tr)
JO (1) JO3488B1 (tr)
LT (2) LT3473619T (tr)
ME (1) ME03325B (tr)
MX (1) MX2017006275A (tr)
MY (1) MY188313A (tr)
NZ (1) NZ730771A (tr)
PE (1) PE20170898A1 (tr)
PH (1) PH12017500881B1 (tr)
PL (1) PL3218366T3 (tr)
PT (2) PT3473619T (tr)
RS (2) RS58347B1 (tr)
SG (1) SG11201703394RA (tr)
SI (2) SI3473619T1 (tr)
SV (1) SV2017005418A (tr)
TN (1) TN2017000116A1 (tr)
TR (1) TR201902686T4 (tr)
TW (1) TWI693218B (tr)
UA (1) UA117983C2 (tr)
WO (1) WO2016077161A1 (tr)
ZA (1) ZA201702199B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3804721A4 (en) * 2018-05-29 2022-03-16 Taiho Pharmaceutical Co., Ltd. ANTITUMORS AGENTS AND METHODS FOR TUMOR THERAPY
JP2022508183A (ja) * 2018-11-30 2022-01-19 イーライ リリー アンド カンパニー 神経芽細胞腫の治療における使用のためのオーロラａキナーゼ阻害剤
CN112239465A (zh) * 2019-07-16 2021-01-19 微境生物医药科技(上海)有限公司 极光激酶抑制剂及其用途
CN112898292A (zh) * 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型极光激酶抑制剂及其用途
TWI785474B (zh) 2020-01-22 2022-12-01 大陸商北京加科思新藥研發有限公司 用作選擇性Aurora A抑制劑的新型雜環化合物
WO2022247816A1 (zh) 2021-05-24 2022-12-01 江苏恒瑞医药股份有限公司 含氮杂环类化合物、其制备方法及其在医药上的应用
AR126581A1 (es) * 2021-07-28 2023-10-25 Jacobio Pharmaceuticals Co Ltd Formas polimórficas de inhibidores selectivos de aurora a y usos de las mismas
WO2023196887A1 (en) 2022-04-08 2023-10-12 Eli Lilly And Company Method of treatment including kras g12c inhibitors and aurora a inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709475B2 (en) * 2004-05-21 2010-05-04 Banyu Pharmaceutical Co., Ltd. Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton
JP2008081492A (ja) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd オーロラａ選択的阻害作用を有する新規アミノピリジン誘導体
US8519136B2 (en) * 2008-02-22 2013-08-27 Msd K.K. Aminopyridine derivatives having aurora a selective inhibitory action
CA2755953A1 (en) * 2009-03-24 2010-09-30 Vertex Pharmaceuticals Incorporated Novel aminopyridine derivatives having aurora a selective inhibitory action
TWI485146B (zh) * 2012-02-29 2015-05-21 Taiho Pharmaceutical Co Ltd Novel piperidine compounds or salts thereof

Also Published As

Publication number Publication date
CN107108567A (zh) 2017-08-29
DK3218366T3 (en) 2019-04-01
RS60999B1 (sr) 2020-11-30
CY1121334T1 (el) 2020-05-29
EP3473619A1 (en) 2019-04-24
ME03325B (me) 2019-10-20
PL3218366T3 (pl) 2019-06-28
SV2017005418A (es) 2018-10-09
AU2015347043A1 (en) 2017-05-04
UA117983C2 (uk) 2018-10-25
CA2963473C (en) 2018-12-18
EA032102B1 (ru) 2019-04-30
DK3473619T3 (da) 2020-09-21
EP3473619B1 (en) 2020-09-09
SI3473619T1 (sl) 2020-10-30
SG11201703394RA (en) 2017-05-30
BR112017007239A2 (pt) 2017-12-19
BR112017007239B1 (pt) 2023-01-31
ES2716732T3 (es) 2019-06-14
ZA201702199B (en) 2018-12-19
KR20170066623A (ko) 2017-06-14
JO3488B1 (ar) 2020-07-05
ECSP17029203A (es) 2018-01-31
AR102463A1 (es) 2017-03-01
EP3218366B1 (en) 2019-01-09
TR201902686T4 (tr) 2019-03-21
CN107108567B (zh) 2020-01-10
LT3218366T (lt) 2019-04-10
WO2016077161A1 (en) 2016-05-19
MY188313A (en) 2021-11-27
AU2015347043B2 (en) 2018-03-22
EP3218366A1 (en) 2017-09-20
US20160137628A1 (en) 2016-05-19
SI3218366T1 (sl) 2019-02-28
IL251406A0 (en) 2017-05-29
TN2017000116A1 (en) 2018-07-04
PE20170898A1 (es) 2017-07-12
US10010540B2 (en) 2018-07-03
US9637474B2 (en) 2017-05-02
TWI693218B (zh) 2020-05-11
EA201790838A1 (ru) 2017-12-29
TW201629038A (zh) 2016-08-16
HRP20201681T1 (hr) 2020-12-25
US20170119751A1 (en) 2017-05-04
CO2017004784A2 (es) 2017-08-31
CL2017001209A1 (es) 2018-01-12
PT3473619T (pt) 2020-11-11
RS58347B1 (sr) 2019-03-29
HUE051530T2 (hu) 2021-03-01
IL251406B (en) 2019-08-29
EP3473619B8 (en) 2020-11-04
JP2016539942A (ja) 2016-12-22
NZ730771A (en) 2018-07-27
LT3473619T (lt) 2020-11-10
PH12017500881A1 (en) 2017-11-06
CA2963473A1 (en) 2016-05-19
HRP20190324T1 (hr) 2019-04-19
CR20170158A (es) 2017-06-21
KR101930182B1 (ko) 2018-12-17
HUE043759T2 (hu) 2019-09-30
CY1123592T1 (el) 2022-03-24
PH12017500881B1 (en) 2017-11-06
PT3218366T (pt) 2019-04-01
ES2826448T3 (es) 2021-05-18
DOP2017000111A (es) 2017-06-15
JP6159029B2 (ja) 2017-07-05

Similar Documents

Publication Publication Date Title
PH12018500792A1 (en) Benzolactam compounds as protein kinase inhibitors
PH12017500881A1 (en) Aurora a kinase inhibitor
NZ763551A (en) Compounds useful for inhibiting cdk7
UA117976C2 (uk) Сполуки амінопіримідинілу як інгібітори jak
MX2017013797A (es) Inhibidor de janus quinasa.
TN2012000622A1 (en) Combinations of kinase inhibitors for the treatment of cancer
WO2015200680A3 (en) Prmt5 inhibitors and uses thereof
PH12015502091A1 (en) Cdc7 inhibitors
TN2015000417A1 (en) Heteroaryl compounds and uses thereof
MX2015011514A (es) Compuestos de heteroarilo y sus usos.
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
PH12019501022A1 (en) Pyrazolopyrimidine compounds and methods of use thereof
WO2016198698A3 (en) P38 inhibitors for the treatment and prophylaxis of liver cancer
MY201291A (en) Aminothiazole compounds as protein kinase inhibitors
MX2019005723A (es) Inhibidor del receptor del factor de crecimiento de fibroblastos 4 (fgfr4) y metodo de preparacion y uso del mismo.

Legal Events

Date Code Title Description
FG Grant or registration